Skip to main content
. 2017 Mar 9;37(6):865–873. doi: 10.1007/s00296-017-3682-9

Table 3.

Change in glucocorticoid use from baseline to Month 6

All patients (n = 44) Mild SLE (n = 3) Moderate SLE (n = 32) Severe SLE (n = 9)
Discontinued, n (%) 5 (11.4) 1 (33.3) 4 (12.5) 0 (0)
Decreased, n (%) 26 (59.1) 0 (0) 20 (62.5) 6 (66.7)
No change, n (%) 10 (22.7) 2 (66.7) 7 (21.9) 1 (11.1)
Increased, n (%) 3 (6.8) 0 (0) 1 (3.1) 2 (22.2)

SLE systemic lupus erythematosus